El-Mofty SK. Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: An update with special
reference to HPV-related carcinomas. Med Oral Patol
Oral Cir Bucal. 2014 Jul 1;19 (4):e377-85.
doi:10.4317/medoral.20184
http://dx.doi.org/doi:10.4317/medoral.20184
|
1. Broder AC. The grading of carcinoma. Minn Med. 1925;8:726. |
|
|
|
|
|
2. Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E. New malignancy grading is a better
prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol
Med. 1989;18:432-7. |
|
|
|
|
|
3. Bryne M, Koppang HS, Lilleng R, Kjaerheim A.
Malignancy grading of the deep invasive margins of oral squamous
cell carcinomas has high prognostic value. J Pathol. 1992;166:375-81. |
|
|
|
|
|
4. Brandwein-Gensler M, Teixeira MS, Lewis CM. Oral squamous cell carcinoma: histologic
risk assessment , but not margin status, is strongly
predictive of local disease-free and overall survival. Am J Surg Pathol.
2005;29:167-178. |
|
|
|
|
|
5. Brandwein-Gensler M, Smith RV, Wang B, Penner C, Theilken A, Broughel D, et al. Validation of the histologic
risk model in a new cohort of patients with head and neck squamous
cell carcinoma. Am J Surg
Pathol. 2010;34:676-688. |
|
|
|
|
|
6. Li Y, Bai S, Carroll W. Validation of
the risk model: High risk classification and tumor pattern of invasion
predict outcome for patients with low stage oral cavity squamous
cell carcinoma. Head Neck
Pathol. 2013;7:211-223. |
|
|
|
|
|
7. El-Mofty SK, Lu DW. Prevalence of human papillomavirus
type 16 DNA in squamous cell carcinoma of the
palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol.
2003;27:1463-70. |
|
|
|
|
|
8. Chaturvedi AK. Epidemiologic and clinical aspects of HPV
in head and neck cancer. Head Neck Pathol. 2012;6:S16-S24. |
|
|
|
|
|
9. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk
factor profiles for human papillomavirus type
16-positive and human papillomavirus type-16
negative head and neck cancer. J Natl Cancer Inst.
2008;100:407-420. |
|
|
|
|
|
10. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Forestiere
A, et al. Improved survival of patients with human papillomavirus
positive head and neck squamous cell carcinoma in a
prospective clinical trial. J Natl Cancer Inst.
2008;100:261-9. |
|
|
|
|
|
11. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis
JS. HPV-related nonkeratinizing squamous
cell carcinoma of the oropharynx: utility of
microscopic features in predicting patient outcome. Head neck Pathol.
2009;3:186-194. |
|
|
|
|
|
12. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI,
Nguyen-Tan PF, et al. Human papillomavirus and
survival of patients with oropharyngeal cancer. N
Eng J Med. 2010;363:24-35. |
|
|
|
|
|
13. El-Mofty
SK, Zhang MQ, Davila RM. Histologic identification of human Papillomavirus (HPV)-related squamous
cell carcinoma in cervical lymph nodes: a reliable predictor of the site of
an occult head and neck primary carcinoma. Head
Neck Pathol. 2008;2:163-8. |
|
|
|
|
|
14. El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal
nonkeratinizing squamous
cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:339-45. |
|
|
|
|
|
15. Syrjanen SM, Syrjanien KJ, Lobe
DC. New concepts on the role of human papillomavirus
in cell cycle regulation. Ann Med.
1999;31:175-187. |
|
|
|
|
|
16. Phelps
WC, Barnes JA, Lobe DC. Molecular targets of human papillomavirus:
prospects for antiviral therapy. Antivir Chem chemother. 1998;9:359-377. |
|
|
|
|
|
17. Wilczynski
SP, Lin BT, Xie Y, Paz
IB. Detection
of human papillomavirue DNA and protein overexpressiomn are associated with a distinctmorphological
pattern of tonsillar squamous
cell carcinoma. Am J Pathol.
1998:152:145-156. |
|
|
|
|
|
18. Klaes R, Friedrich T, Spitkovsky
D, Ridder R, Rudi W, Petry
U, et al. Overexpression of p16(INK4A) as a
specific marker for dysplastic and neoplastic cells
of the cervix uteri. Int J Cancer. 2001;92:276-284. |
|
|
|
|
|
19. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis
JS. HPV-related nonkeratinizing squamous
cell carcinoma of the oropharynx: Utility of
microscopic features in predicting patient outcome. Head Neck pathol.
2009;3:186-194. |
|
|
|
|
|
20. Lewis
JS, Thorstad WL, Chernock
RD, Haughey BH, Yip JH, Zhang Q, et al. p16
positive oropharyngeal squamous
cell carcinoma: an Entity with favorable prognosis regardless of tumor HPV
status. Am J Surg Pathol.
2010;34:1088-1096. |
|
|
|
|
|
21. Lewis
JS, Chernock RD, Ma X-J, Flanagan JJ, Yuling L, Gao
G, et al. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate
with human papillomavirus RNA status. Mod Pathol. 2012;25:1212-1220. |
|
|
|
|
|
22. Molden T, Krause I, Skomedal H,
Nordstrom T, Karlsen F. PreTech
HPV-proofer; real time detection and typing of E6/E7 mRNA from carcinogenic
human papillomavirus. J Viro Methods. 2007;142:204-212. |
|
|
|
|
|
23. Gao G, Chernock RD, Gay HA, Thorstad WL, Zhang TR, Wang H, et al. A novel RT-PCR
method for quantification of human papilomavirus
transcripts in archival tissue and its application in oropharyngeal
cancer prognosis. Int J Cancer. 2013;132:882-890. |
|
|
|
|
|
24. Bishop
JA, Ma XJ, Wang H, Luo Y, Illei
BB, Begun S, et al. detection of transcriptionally
active high risk HPV in patients with head and neck squamous
cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization
method. Am J Surg Pathol.
2012;36:1874-1882. |
|
|
|
|
|
25. Ukpo OC, Flanagan JJ, Ma XJ, Luo
Y, Thorstad WL, Lewis JS. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ
hybridization assay strongly correlates with p16 expression and patient
outcomes in oropharyngeal squamous
cell carcinoma. Am J Surg Pathol.
2011;35:1343-1350. |
|
|
|
|
|
26. Lewis
JS. Scantlebury JB, Luo
J, Thorstad WL. Tumor cell anaplasia
and multinucleation are
predictor of disease recurrence in oropharyngeal squamous cell carcinoma, including among just the Human papillomavirus-related cancers. Am J Surg
Pathol. 2012;36:1036-1046. |
|
|
|
|
|
27.
Nicholas AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, et al. Bcl2 and human papillomavirus
16 as predictor of outcome following concurrent chemoradiation
for advanced oropharyngeal cancer. Clin Cancer Res. 2010;16:2138-2146. |
|
|
|
|
|
28. Huang
SH, Perez-Ordonez B, Liu FF, Waldron J, Ringash J,
Irish J, et al. Atypical clinical behavior of p16 confirmed HPV related oropharyngeal squamous cell
carcinoma treated with radical radiotherapy. Int J
Radiation Oncology Biol Phys. 2012;82:276-283. |
|
|
|
|
|
29. Muller
S, Khuri F, Kono SA, Beitler JJ, Shin DM, Saba NF. HPV positive squamous cell carcinoma of the oropharynx.
Are we observing an unusual pattern of metastasis.
Head Neck Pathol. 2012;6:336-344. |
|
|
|
|
|
30. Reimers
N, Kasper HU, Weissenborn
SJ, Stutzer H, Preuss FS,
Hoffmann TK, et al. Combined analysis of HPV-DNA and EGFR
expression to predict prognosis in oropharyngeal
cancer. Int J Cancer. 2007;120:1731-8. |
|
|
|
|
|
31. Kumar
B, Gordell KG, Lee JS, Worden FP, Prince ME, Tran
HH, et al. EGFR, p16, HPV titer, Bcl-xL and p53,
sex and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128-3137. |
|
|
|
|
|
32. Ha PK,
Pai SI, Westran WH, Gillison ML, Tong BC, Sidransky
D, et al. Real time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant
lesions of the oral cavity Clin Cancer Res.
2002;8:1203-9. |
|
|
|
|
|
33. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers
HJ, Leemans CR, et al. Genetic patterns in head and
neck cancers that contain or lack transcriptionally
active human papillomavirus. J Natl
Cancer Inst. 2004;96:998-1006. |
|
|
|
|
|
34. Schlecht NF, Brandwein-Gensler
M, Nuovo GJ, Li M, Dunn A, Kawachi
N, et al. A comparison of clinically utilized papillomavirus
detection methods in head and neck cancer. Mod pathol.
2011;24:1295-1305. |
|
|
|
|
|
35. Lewis JS, Ukbo
OC, Ma X-J, Flanagan JJ, Luo Y, Thorstad WL, et al. Transcriptionally-active high-risk human papillomavirus is rare in oral and laryngeal/hypopharyngeal squamous cell
carcinoma- a tissue microarray study utilizing E6/E7 mRNA in situ
hybridization. Histopathology. 2012;60:982-991. |
|
|
|
|
|
36. Chernock RD, Lewis JS, Zhang Q, El-Mofty
SK. Human papillomavirus positive basaloid squamous cell
carcinoma of the upper aerodigestive tract: a
distinct clinicopathologic and molecular subtype of
basaloid squamous cell
carcinoma. Hum Pathol. 2010;41:1016-1023. |
|
|
|
|
|
37. Begum
S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed
variant that can be further resolved by HPV status. Am J Surg
Pathol. 2008;32;1044-1050. |
|
|
|
|
|
38. Nicholls
JM, Agathanggelou A, Fung K, Zeng
X, Niedobitek G. The association of squamous cell carcinomas of the nasopharynx
with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol.
1997;183:164-8. |
|
|
|
|
|
39.
Carpenter D, El-Mofty SK, Lewis JS. Undifferentiated
carcinoma of the oropharynx: A human papillomavirus associated tumor with favorable prognosis.
Mod Pathol. 2011;24:1306-1312. |
|
|
|
|
|
40. Singhi AD, Stelow EB, Mills SE,
Westra WH. Lymphoepithelial-like
carcinoma of the oropharynx ; A morphologic variant
of HPV related head and neck carcinoma. Am J Surg Pathol. 2010;34:800-805. |
|
|
|
|
|
41. Jo VY,
Mills SE, Stoler MH, Stelow
EB. Papillary squamous cell carcinoma of the head
and neck. Frequent infection with human papillomavirus
infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-4. |
|
|
|
|
|
42. Mehrad M, Carpenter DH, Chernock
RD, Wang H, Ma X-J, Luo Y, et al. Papillary squamous cell carcinoma of the head and neck: Clinicopathologic and molecular features with special
reference to human papillomavirus. Am J Surg Pathol. 2013;37:1349-1356. |
|
|
|
|
|
43. Bishop
JA, Westra WH. Human papillomavirus-related
small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011:35:1679-1684. |
|
|
|
|
|
44. Kraft
S, Faquin WC, Krane JF.
HPV-associated neuroendoctine carcinoma of the oropharynx: a rare entity with potentially aggressive
clinical behavior. Am J Surg Pathol.
2012;36:321-330. |
|
|
|
|
|
45. Abeler VM, Holm R, Nesland JM, Kjørstad KE. Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients. Cancer. 1994;73:672-7. |
|
|
|
|
|
46. Wang
KL, Yang YC, Wang TY, Chen JR, Chen TC, Chen HS, et al. Neuroendocrine
carcinoma of the uterine cervix: A clinicopathologic
retrospective study of 31 cases with prognostic implications. J Chemother. 2006;18:209-16. |
|
|
|
|
|
47. Cai C, Chernock RD, Pittman ME,
El-Mofty SK, Thorstad WL,
Lewis JS. Keratinizing-Type Squamous Cell Carcinoma
of the Oropharynx: p16 Overexpression
Is Associated With Positive High-Risk HPV Status and Improved Survival. Am J Surg Pathol.
2014;38:809-15. |
|
|
|
|
|
48. Lu DW,
El-Mofty SK, Wang H. Expression of p16, Rb and p53 proteins in squamous
cell carcinoma of the anorectal region harboring
human papillomavirus DNA. Modern Pathol. 2003;16:692-9. |
|
|
|
|
|
49. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing
(cylindrical cell) carcinoma of the sinonasal
tract: a distinct clinicopathologic and molecular
disease entity. Am J Surg Pathol.
2005;29:1367-72. |
|